JOB DESCRIPTION: About Abbott Abbott is a global healthcare leader, creating breakthrough science to improve people’s health. We’re always looking towards the future, anticipating changes in medical science and technology. In Germany, Abbott has more than
About AIRS Medical AIRS Medical is a fast-growing healthcare technology company founded in 2018 and headquartered in Seoul, South Korea, with rapidly expanding U.S. EMEA and Japan operations. Built on the belief that technology should help
About AIRS Medical AIRS Medical is a fast-growing healthcare technology company founded in 2018 and headquartered in Seoul, South Korea, with rapidly expanding U.S. EMEA and Japan operations. Built on the belief that technology should help
About AIRS Medical AIRS Medical is a fast-growing healthcare technology company founded in 2018 and headquartered in Seoul, South Korea, with rapidly expanding U.S. EMEA and Japan operations. Built on the belief that technology should help
About AIRS Medical AIRS Medical is a fast-growing healthcare technology company founded in 2018 and headquartered in Seoul, South Korea, with rapidly expanding U.S. EMEA and Japan operations. Built on the belief that technology should help
About Abbott Abbott is a global healthcare leader, creating breakthrough science to improve peoples health. Were always looking towards the future, anticipating changes in medical science and technology. In Germany, Abbott has more than 4,000 employees
About Abbott Abbott is a global healthcare leader, creating breakthrough science to improve peoples health. Were always looking towards the future, anticipating changes in medical science and technology. In Germany, Abbott has more than 4,000 employees
Sind Sie ein erfahrener Contract & Claim Manager und möchten zum grünen Wandel beitragen? Werden Sie Teil unseres wachsenden Teams in Hamburg und tragen Sie zu einigen der spannendsten Entwicklungen im Bereich der erneuerbaren Energien bei.
Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a